Photo from Agenus/LinkedIn
Apr 13, 2024, 06:43
Agenus announced updated Phase 1 data and progress botensilimab/balstilimab combination in metastatic MSS colorectal cancer
Agenus shared on LinkedIn:
“Today we announced updated Phase 1 data and progress on our investigational botensilimab/balstilimab combination in patients with metastatic MSS colorectal cancer. Get the latest.”
Source: Agenus/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 10:47
Feb 22, 2025, 05:18
Feb 22, 2025, 05:15
Feb 22, 2025, 05:05
Feb 22, 2025, 04:54
Feb 22, 2025, 04:49
Feb 22, 2025, 04:33